Annatto-extracted tocotrienols improve glucose homeostasis and bone properties in high-fat diet-induced type 2 diabetic mice by decreasing the inflammatory response

[1]  Dongwei Fan,et al.  Diabetes mellitus is a risk factor for low bone mass-related fractures , 2017, Medicine.

[2]  Chwan-Li Shen,et al.  A High-Fat Diet Decreases Bone Mass in Growing Mice with Systemic Chronic Inflammation Induced by Low-Dose, Slow-Release Lipopolysaccharide Pellets. , 2017, The Journal of nutrition.

[3]  Chwan-Li Shen,et al.  Effects of delta-tocotrienol on obesity-related adipocyte hypertrophy, inflammation and hepatic steatosis in high-fat-fed mice. , 2017, The Journal of nutritional biochemistry.

[4]  I. Kanazawa.  Interaction between bone and glucose metabolism [Review]. , 2017, Endocrine journal.

[5]  S. Ima-Nirwana,et al.  Tocotrienols for bone health: a translational approach , 2017, Annals of the New York Academy of Sciences.

[6]  A. Schwartz,et al.  Mechanisms of diabetes mellitus-induced bone fragility , 2017, Nature Reviews Endocrinology.

[7]  L. Ward,et al.  Anti-inflammatory γ- and δ-tocotrienols improve cardiovascular, liver and metabolic function in diet-induced obese rats , 2017, European Journal of Nutrition.

[8]  J. Olefsky,et al.  Inflammatory mechanisms linking obesity and metabolic disease , 2017, The Journal of clinical investigation.

[9]  H. Mo,et al.  Peroxisome proliferator-activated receptor γ down-regulation mediates the inhibitory effect of d-δ-tocotrienol on the differentiation of murine 3T3-F442A preadipocytes. , 2016, Nutrition research.

[10]  D. Choi,et al.  Natural Phyto-Bioactive Compounds for the Treatment of Type 2 Diabetes: Inflammation as a Target , 2016, Nutrients.

[11]  M. Snyder,et al.  Metformin Improves Diabetic Bone Health by Re-Balancing Catabolism and Nitrogen Disposal , 2015, PloS one.

[12]  Neda Haghighat,et al.  Effect of Tocotrienols enriched canola oil on glycemic control and oxidative status in patients with type 2 diabetes mellitus: A randomized double-blind placebo-controlled clinical trial , 2015, Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences.

[13]  H. Ahsan,et al.  Pharmacological potential of tocotrienols: a review , 2014, Nutrition & Metabolism.

[14]  S. Ima-Nirwana,et al.  Annatto Tocotrienol Improves Indices of Bone Static Histomorphometry in Osteoporosis Due to Testosterone Deficiency in Rats , 2014, Nutrients.

[15]  L. Deng,et al.  γ-Tocotrienol protects against ovariectomy-induced bone loss via mevalonate pathway as HMG-CoA reductase inhibitor. , 2014, Bone.

[16]  M. Marshall,et al.  Gamma-tocotrienol attenuates high-fat diet-induced obesity and insulin resistance by inhibiting adipose inflammation and M1 macrophage recruitment , 2014, International Journal of Obesity.

[17]  H. Ahsan,et al.  Protective effects of tocotrienols against lipid-induced nephropathy in experimental type-2 diabetic rats by modulation in TGF-β expression. , 2013, Toxicology and applied pharmacology.

[18]  C. Kiyose,et al.  Gamma-tocotrienol reduces the triacylglycerol level in rat primary hepatocytes through regulation of fatty acid metabolism , 2012, Journal of clinical biochemistry and nutrition.

[19]  J. Kanis,et al.  Type 2 diabetes and bone , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[20]  D. A. Luke,et al.  Two Different Isomers of Vitamin E Prevent Bone Loss in Postmenopausal Osteoporosis Rat Model , 2012, Evidence-based complementary and alternative medicine : eCAM.

[21]  Norazlina Mohamed,et al.  Effects of Tocotrienol and Lovastatin Combination on Osteoblast and Osteoclast Activity in Estrogen-Deficient Osteoporosis , 2012, Evidence-based complementary and alternative medicine : eCAM.

[22]  E. Keats,et al.  Unique Responses of Stem Cell-Derived Vascular Endothelial and Mesenchymal Cells to High Levels of Glucose , 2012, PloS one.

[23]  J. Smolen,et al.  Inflammatory bone loss: pathogenesis and therapeutic intervention , 2012, Nature Reviews Drug Discovery.

[24]  R. Brooks,et al.  Direct inhibition of osteoclast formation and activity by the vitamin E isomer gamma-tocotrienol. , 2011, International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition.

[25]  M. Diamond-Stanic,et al.  Oxidative stress and the etiology of insulin resistance and type 2 diabetes. , 2011, Free radical biology & medicine.

[26]  M. Emre,et al.  Deterioration of Bone Quality by Streptozotocin (STZ)-Induced Type 2 Diabetes Mellitus in Rats , 2011, Biological Trace Element Research.

[27]  Z. Lee,et al.  α-Tocotrienol inhibits osteoclastic bone resorption by suppressing RANKL expression and signaling and bone resorbing activity. , 2011, Biochemical and biophysical research communications.

[28]  D. Lippner,et al.  The bone marrow microenvironment contributes to type I diabetes induced osteoblast death , 2011, Journal of cellular physiology.

[29]  Yong-hui Shi,et al.  Dyslipidemic high-fat diet affects adversely bone metabolism in mice associated with impaired antioxidant capacity. , 2011, Nutrition.

[30]  Ganesh V. Halade,et al.  Obesity-mediated inflammatory microenvironment stimulates osteoclastogenesis and bone loss in mice , 2011, Experimental Gerontology.

[31]  R. O. Ritchie,et al.  Changes in cortical bone response to high-fat diet from adolescence to adulthood in mice , 2010, Osteoporosis International.

[32]  Ralph Müller,et al.  Guidelines for assessment of bone microstructure in rodents using micro–computed tomography , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[33]  M. Sjöström,et al.  The Human Visceral Fat Depot Has a Unique Inflammatory Profile , 2010, Obesity.

[34]  Li Sun,et al.  Diet‐induced obesity alters bone remodeling leading to decreased femoral trabecular bone mass in mice , 2010, Annals of the New York Academy of Sciences.

[35]  A. Shuid,et al.  Vitamin E exhibits bone anabolic actions in normal male rats , 2010, Journal of Bone and Mineral Metabolism.

[36]  K. Nakagawa,et al.  Tocotrienol distribution in foods: estimation of daily tocotrienol intake of Japanese population. , 2010, Journal of agricultural and food chemistry.

[37]  A. Amalfitano,et al.  Bone inflammation and altered gene expression with type I diabetes early onset , 2009, Journal of cellular physiology.

[38]  Srijit Das,et al.  The Effects of Palm Oil Tocotrienol-Rich Fraction Supplementation on Biochemical Parameters, Oxidative Stress and the Vascular Wall of Streptozotocin-Induced Diabetic Rats , 2009, Clinics.

[39]  Jing Hu,et al.  Metformin regulates osteoblast and adipocyte differentiation of rat mesenchymal stem cells , 2008, The Journal of pharmacy and pharmacology.

[40]  G. Banfi,et al.  Oxidative stress, free radicals and bone remodeling , 2008, Clinical chemistry and laboratory medicine.

[41]  P. Portincasa,et al.  Oxidative stress-induced risk factors associated with the metabolic syndrome: a unifying hypothesis. , 2008, The Journal of nutritional biochemistry.

[42]  Nihal Ahmad,et al.  Dose translation from animal to human studies revisited , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[43]  S. Sheweita,et al.  Calcium metabolism and oxidative stress in bone fractures: role of antioxidants. , 2007, Current drug metabolism.

[44]  M. Saito,et al.  Role of collagen enzymatic and glycation induced cross-links as a determinant of bone quality in spontaneously diabetic WBN/Kob rats , 2006, Osteoporosis International.

[45]  B. Nicklas,et al.  Chronic inflammation: role of adipose tissue and modulation by weight loss. , 2006, Current diabetes reviews.

[46]  Nils Welsh,et al.  Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities. , 2005, Diabetes.

[47]  A. Rezania,et al.  Development of an ectopic site for islet transplantation, using biodegradable scaffolds. , 2005, Tissue engineering.

[48]  S. Shoelson,et al.  Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB , 2005, Nature Medicine.

[49]  A. Schwartz,et al.  Diabetes Mellitus: Does it Affect Bone? , 2003, Calcified Tissue International.

[50]  G. Panfili,et al.  Normal phase high-performance liquid chromatography method for the determination of tocopherols and tocotrienols in cereals. , 2003, Journal of agricultural and food chemistry.

[51]  M. Drezner,et al.  Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committee , 1987, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[52]  I. Kanazawa,et al.  Association of Bone Mineral Density, Bone Turnover Markers, and Vertebral Fractures with All-Cause Mortality in Type 2 Diabetes Mellitus , 2017, Calcified Tissue International.

[53]  I. Kanazawa.  Interaction between bone and glucose metabolism , 2017 .

[54]  Jerrold M. Olefsky,et al.  Regulation of metabolism by the innate immune system , 2016, Nature Reviews Endocrinology.

[55]  A. Nazrun,et al.  Low dose of tocotrienols protects osteoblasts against oxidative stress. , 2011, La Clinica terapeutica.

[56]  B. Zinman,et al.  Effect of rosiglitazone, metformin, and glyburide on bone biomarkers in patients with type 2 diabetes. , 2010, The Journal of clinical endocrinology and metabolism.

[57]  R. Ziegler,et al.  Diabetes mellitus a risk for osteoporosis? , 2001, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.